Bente A Talseth-Palmer

Summary

Affiliation: University of Newcastle
Country: Australia

Publications

  1. ncbi Whole genome amplification and its impact on CGH array profiles
    Bente A Talseth-Palmer
    School of Biomedical Sciences, Faculty of Health, University of Newcastle and the Hunter Medical Research Institute, NSW, Australia
    BMC Res Notes 1:56. 2008
  2. ncbi A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology
    B A Talseth-Palmer
    Faculty of Health, School of Biomedical Sciences, University of Newcastle and the Hunter Medical Research Institute, Newcastle, NSW, Australia
    Cytogenet Genome Res 124:94-101. 2009
  3. ncbi MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
    Bente A Talseth-Palmer
    School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW 2308, Australia
    Hered Cancer Clin Pract 8:5. 2010
  4. ncbi Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome
    Bente A Talseth-Palmer
    School of Biomedical Sciences and Pharmacy, University of Newcastle, HMRI, Room 3642, Level 3, John Hunter Hospital, Newcastle, Australia
    J Med Genet 48:279-84. 2011
  5. ncbi Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age
    Zumin Shi
    Research Centre for Gender, Health and Ageing, University of Newcastle, Callaghan, Australia
    Int J Cancer 125:78-83. 2009
  6. ncbi P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
    Kelly A Avery-Kiejda
    Oncology and Immunology, Calvary Mater Newcastle Hospital, University of Newcastle, Newcastle, NSW, Australia
    BMC Cancer 11:203. 2011

Collaborators

Detail Information

Publications6

  1. ncbi Whole genome amplification and its impact on CGH array profiles
    Bente A Talseth-Palmer
    School of Biomedical Sciences, Faculty of Health, University of Newcastle and the Hunter Medical Research Institute, NSW, Australia
    BMC Res Notes 1:56. 2008
    ..Four experiments were conducted on amplified DNA compared to unamplified DNA and two experiments on unamplified DNA compared to unamplified DNA...
  2. ncbi A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology
    B A Talseth-Palmer
    Faculty of Health, School of Biomedical Sciences, University of Newcastle and the Hunter Medical Research Institute, Newcastle, NSW, Australia
    Cytogenet Genome Res 124:94-101. 2009
    ..The results of this study suggest that it may be desirable to investigate idiopathic mental retardation using genome-wide SNP arrays, in conjunction with other cytogenetic and molecular techniques...
  3. ncbi MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
    Bente A Talseth-Palmer
    School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW 2308, Australia
    Hered Cancer Clin Pract 8:5. 2010
    ..This study reports on our findings on mutation type, cancer risk and age of diagnosis in MSH6 and PMS2 families...
  4. ncbi Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome
    Bente A Talseth-Palmer
    School of Biomedical Sciences and Pharmacy, University of Newcastle, HMRI, Room 3642, Level 3, John Hunter Hospital, Newcastle, Australia
    J Med Genet 48:279-84. 2011
    ..The objective of this study was to genotype nine SNPs within these six loci to confirm previous findings and investigate whether they act as modifiers of disease risk in patients with Lynch syndrome...
  5. ncbi Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age
    Zumin Shi
    Research Centre for Gender, Health and Ageing, University of Newcastle, Callaghan, Australia
    Int J Cancer 125:78-83. 2009
    ..Understanding the mechanisms by which HFE interrelates with colorectal malignancies could lead to reduction of disease risk in HNPCC...
  6. ncbi P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
    Kelly A Avery-Kiejda
    Oncology and Immunology, Calvary Mater Newcastle Hospital, University of Newcastle, Newcastle, NSW, Australia
    BMC Cancer 11:203. 2011
    ..While mutation of the P53 tumour suppressor gene is a common feature of many types of cancer, mutational inactivation of P53 in melanoma is uncommon; however, its function often appears abnormal...